Qiankang Technology

Hunan Qiankang Technology Co., Ltd. is a Sino-foreign joint venture in biotechnology dedicated to research on cutting-edge medical laboratory technology. It is a modern national high-tech enterprise and "dual-software certification" enterprise integrating R&D, production, and sales. Founded in July 2014, it is headquartered in Changsha, Hunan, with its R&D center located in Melbourne, Australia, and has established long-term scientific research cooperation with cutting-edge Australian research institutes. Relying on the Australian research platform, the company has assembled a team of top-tier scientific and technological talents led by internationally leading scientists, and continues to increase its R&D investment. In 2018, the company passed the ISO13485:2003 medical device quality management system certification and obtained CE certification. Focusing on worldwide detection challenges, the company has spent years developing an international patent (PCT) product for early screening of Alzheimer's disease (AD) - a urine β-amyloid protein detection kit, which breakthroughly achieves rapid in vitro detection of AD based on urine, providing a broad-spectrum and effective means for early AD screening globally. To date, it has applied for more than 160 invention patents, utility model patents, software products, and computer software copyrights. Looking ahead, Qiankang Technology will continue to uphold its mission of "creating cutting-edge technology, serving public health," focusing on core technologies, integrating global resources, persisting in innovation, and continuously developing to serve public health! Company Honors: In 2016, 2 people selected for Changsha 3635 Talent Program; In 2017, won the Municipal-level Intelligence Introduction Special Project Award; In 2017, won the Changsha Innovation and Entrepreneurship Driving Employment Demonstration Project Award; In 2017, won the Hunan Provincial Science and Technology Innovation Platform and Talent Program Project Award; In 2017, Changsha Intelligent Manufacturing Pilot Enterprise; In 2017, Changsha Two-Oriented Enterprise; In 2018, won the Changsha Fourth Batch Intelligent Manufacturing Enterprise Award; In 2018, won the first prize in the Changsha "China Chuangyi" Entrepreneurship and Innovation Competition; In 2018, National High-tech Enterprise; In 2018, Changsha Entrepreneurship and Innovation Driving Employment Demonstration Project; In 2018, Changsha "Hai Zhi Plan" Workstation; In 2018, 1 person selected for Changsha ** Talent Program; In 2018, Participating Unit of the Ministry of Science and Technology Key R&D Program "Active Health and Aging Response"; In 2018 and 2019, Hunan Provincial Intelligence Introduction Project; In 2019, Changsha High-level and Cutting-edge Talent Project; In 2019, Changsha Key Science and Technology Plan Project; In 2019, won the Changsha Science and Technology "Hai Zhi Plan" Outstanding Enterprise Award; In 2020, won the Changsha Introduction of Urgently Needed Strategic Talent Award; In 2020, second prize in the Ministry of Industry and Information Technology "Maker China" Changsha Division; In 2020, Ministry of Science and Technology National Foreign Expert Project "COVID-19 Prevention and Control Special Project". Company Patent Applications: 2 PCT patents; 15 invention patent applications; 17 utility model patents, 14 authorized; 12 software copyrights, 11 authorized; 2 software products.